We use cookies and similar technologies to run this website. See Terms and Conditions.

Online education for healthcare professionals
Physician's chats
Pharmacist's chats
Access to free materials
Under CPD accreditation
60 min

Obesity, part 2 : the potential risk factor contributing to clinical manifestations of COVID 19

27 Jul Tuesday
3 : 00 PM Dubai (GMT +4)
It's over
Documentation for this webinar is presented to the Dubai Health Authority and CPD standards
For Pharmacists, Soft skills


This webinar is under CPD accreditation in MOHAP

We invite physicians, clinical pharmacists and pharmacists to the Obesity, part 2 : the potential risk factor contributing to clinical manifestations of COVID 19 webinar.

Obesity is a potential risk factor contributing to clinical manifestations of COVID-19 it has reached epidemic proportions in the much of the developed world, resulting in significant morbidity. Several of these obesity-related morbidities have been linked to a higher risk of death from coronavirus infection in 2019 (COVID-19).

Besides advanced age and the presence of numerous comorbidities as most important contributors to an elevated risk of severe disease and deadly outcome from Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19), there is now emerging evidence that overweight and obesity predispose to severe symptoms and negative prognosis. Surprisingly, the severity of COVID-19 appears to rise with increasing body mass index (BMI). The association between COVID-19 outcomes and overweight/obesity has biological and physiological plausibility.

During this webinar with Dr Talar Ahmad we will explain: the genomic structure of SARS-CoV-2, mechanisms of virus entry, the life- cycle- of a coronavirus, the role of ACE2 in COVID-19 pathophysiology, including factors influencing ACE2 expression and activity in relation to COVID-19 severity.

In addition, we will discuss the relevant pathological changes resulting from SARS-CoV-2 infection. Obesity and other comorbidities will be also explained.

 Obesity as the risk factor for severe COVID-19 in accompanied with other comorbidities.

Target audience:

  • Physicians
  • Clinical Pharmacists
  • General medical practice
  • Gynecologists
  • Pediatrics medicine 
  • Pharmacists

We kindly remind you that after every webinar participation on PharmaCourses platform you get the named certificates that you can use in future for career promotion and salary increase. 

In order to get this, you have to completely fill in all the fields in your Profile on PharmaCourses: First and Last Name,  Phone, Country, “Occupation” and “Work information” sections.

Colleagues, haven't you joined our PharmaCourses Telegram chat yet?

In the chat of more than 1,800 participants, you can always discuss breaking news and difficult situations in a pharmacy or clinic with your colleagues. Places in the chat are limited, hurry up to get there.

Telegram chat for pharmacists: https://t.me/joinchat/V1F38sTkrGnz8qHe

Telegram chat for physicians: https://t.me/joinchat/v_RlWGJw7LBhNGY0


Dr Talar Ahmad

Invite a colleague

You will get +25
for every participant you invite to this webinar.

For each participant invited to the webinar, you will get 25

PharmaCoins will be accrued after you and your invited guest attend this webinar. It is not allowed to send link in PharmaCourses group chats (Telegram/WA/Facebook/Instagram). In case the Platform has any doubts about the correctness of the fulfillment of this condition, it has right to request screenshots.

You can invite no more than 5 people per day.

Link copied

Fill in this field

Fill in this field

Fill in this field

Fill in this field

Fill in this field

Fill in this field

Fill in this field

Fill in this field

Please enter the valid phone number

Fill in this field